Harrisburg,  PA 
United States
  • Booth: 635

Join us in the fight to eliminate blindness caused by AMD.

MacuLogix® equips eye care professionals with the only automated functional test to measure the speed of dark adaptation, which can be useful in detecting age-related macular degeneration (AMD) and monitoring disease progression. By leveraging the science of dark adaptation through its AdaptDx® and AdaptDx Pro® guided by Theia™, MacuLogix is working toward eliminating preventable blindness caused by AMD—a chronic, progressive disease that impacts nearly 200 million people worldwide and goes undiagnosed in 25 percent of patients. MacuLogix’s team of Practice Management Consultants help eye care professionals maximize their investment to benefit their patients and potentially increase practice revenue.

For Technical Support with this webpage, please contact support

For exhibit questions please contact Grayson Lutz.